Overview / Abstract: |
Target Audience Activity Overview This activity is aimed to improve clinicians’ knowledge about the incidence and risk of ONJ associated with antiresorptive therapies, and present guideline-recommended strategies on how to optimize treatment and mitigate the risk for ONJ to improve clinical outcomes for patients affected by this widely prevalent disease. In addition, strategies to coordinate communication among the disciplines caring for at-risk patients will also be reviewed. Learning Objectives Recognize and appropriately manage patients at risk for osteonecrosis of the jaw (ONJ) |
Expiration |
Feb 26, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.5 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Pamela L. Alberto, DMD |
Sponsors / Supporters / Grant Providers |
Amgen Inc. |
Keywords / Search Terms |
Relias LLC Relias, Free CME, ONJ Free CE CME |